Suppr超能文献

BRCA1/2 突变携带者结直肠癌的表型特征。

Phenotypic characteristics of colorectal cancer in BRCA1/2 mutation carriers.

机构信息

Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Institute of Oncology, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.

出版信息

Eur J Hum Genet. 2018 Mar;26(3):382-386. doi: 10.1038/s41431-017-0067-1. Epub 2018 Jan 10.

Abstract

Mutations in the BRCA1/2 genes were recently shown to be associated with an increased risk for colorectal cancer. We characterized the largest cohort available of BRCA1/2 mutation carriers with colorectal cancer. We analyzed 32 patients with lower gastrointestinal cancers and germline BRCA1/2 mutations from two large academic hospital registries; 91% of patients were of Ashkenazi ancestry, 78% were women, and 62.5% were carriers of BRCA1 gene mutations. A high percentage of colorectal tumors (34.5%) had a mucinous histology and were located atypically in the left colon. Two patients had anal cancer with unusual histology and an additional patient had mucinous small bowel carcinoma. Gene expression analysis showed significant correlation between the gene signatures of left mucinous colorectal cancer and basal-like breast cancer. Our results imply that Ashkenazi BRCA1/2 mutation carriers with colorectal cancer might have unique characteristics with a high rate of left-sided, mucinous histology colorectal cancer, and possibly anal carcinoma. This report suggests a phenotypic influence of defects in DNA repair genes on colorectal tumors.

摘要

BRCA1/2 基因的突变最近被证明与结直肠癌风险增加有关。我们对具有结直肠癌的最大 BRCA1/2 基因突变携带者队列进行了特征描述。我们分析了来自两个大型学术医院登记处的 32 例下消化道癌症和种系 BRCA1/2 突变患者;91%的患者为阿什肯纳兹血统,78%为女性,62.5%为 BRCA1 基因突变携带者。高比例的结直肠肿瘤(34.5%)具有黏液组织学特征,并且位于左结肠的非典型位置。两名患者患有罕见组织学特征的肛门癌,另有一名患者患有黏液性小肠癌。基因表达分析显示左黏液性结直肠癌和基底样乳腺癌的基因特征之间存在显著相关性。我们的结果表明,具有结直肠癌的阿什肯纳兹 BRCA1/2 突变携带者可能具有独特的特征,即左侧黏液性结直肠癌发生率高,可能还有肛门癌。本报告提示 DNA 修复基因缺陷对结直肠肿瘤有表型影响。

相似文献

1
Phenotypic characteristics of colorectal cancer in BRCA1/2 mutation carriers.
Eur J Hum Genet. 2018 Mar;26(3):382-386. doi: 10.1038/s41431-017-0067-1. Epub 2018 Jan 10.
2
Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res Treat. 2017 Jun;163(3):565-571. doi: 10.1007/s10549-017-4198-4. Epub 2017 Mar 25.
3
Male BRCA mutation carriers: clinical characteristics and cancer spectrum.
BMC Cancer. 2018 Feb 13;18(1):179. doi: 10.1186/s12885-018-4098-y.
4
Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin.
Oncogene. 2010 Jan 7;29(1):26-33. doi: 10.1038/onc.2009.301. Epub 2009 Oct 5.
5
Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.
Hum Reprod. 2016 May;31(5):1126-32. doi: 10.1093/humrep/dew044.
8
Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: clinical, pathological, and family characteristics.
Breast Cancer Res Treat. 2010 Nov;124(1):251-8. doi: 10.1007/s10549-010-0853-8. Epub 2010 Apr 7.

引用本文的文献

2
Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer.
Cancers (Basel). 2022 Mar 9;14(6):1388. doi: 10.3390/cancers14061388.
3
Case Report Series: Aggressive HR Deficient Colorectal Cancers Related to BRCA1 Pathogenic Germline Variants.
Front Oncol. 2022 Feb 24;12:835581. doi: 10.3389/fonc.2022.835581. eCollection 2022.
4
Targeting BRCA and DNA Damage Repair Genes in GI Cancers: Pathophysiology and Clinical Perspectives.
Front Oncol. 2021 Oct 11;11:662055. doi: 10.3389/fonc.2021.662055. eCollection 2021.
6
Mucinous Histology, Mutations, and Elevated Tumor Mutational Burden in Colorectal Cancer.
J Oncol. 2020 Apr 25;2020:6421205. doi: 10.1155/2020/6421205. eCollection 2020.
7
AGA Clinical Practice Update on Colorectal and Pancreatic Cancer Risk and Screening in BRCA1 and BRCA2 Carriers: Commentary.
Gastroenterology. 2020 Aug;159(2):760-764. doi: 10.1053/j.gastro.2020.03.086. Epub 2020 Apr 23.

本文引用的文献

1
Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
J Clin Oncol. 2017 Apr 1;35(10):1086-1095. doi: 10.1200/JCO.2016.71.0012. Epub 2017 Jan 30.
2
Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer.
Nat Rev Cancer. 2017 Feb;17(2):79-92. doi: 10.1038/nrc.2016.126. Epub 2017 Jan 4.
3
BRCAness revisited.
Nat Rev Cancer. 2016 Feb;16(2):110-20. doi: 10.1038/nrc.2015.21. Epub 2016 Jan 18.
4
The consensus molecular subtypes of colorectal cancer.
Nat Med. 2015 Nov;21(11):1350-6. doi: 10.1038/nm.3967. Epub 2015 Oct 12.
5
Advances in the care of patients with mucinous colorectal cancer.
Nat Rev Clin Oncol. 2016 Jun;13(6):361-9. doi: 10.1038/nrclinonc.2015.140. Epub 2015 Sep 1.
7
C-reactive protein and colorectal cancer mortality in U.S. adults.
Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1609-18. doi: 10.1158/1055-9965.EPI-13-0577. Epub 2014 May 27.
8
Colorectal cancer statistics, 2014.
CA Cancer J Clin. 2014 Mar-Apr;64(2):104-17. doi: 10.3322/caac.21220. Epub 2014 Mar 17.
9
Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study.
Br J Cancer. 2014 Jan 21;110(2):530-4. doi: 10.1038/bjc.2013.741. Epub 2013 Nov 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验